STOCK TITAN

Inari Medical Announces the Release of 2023 Ethos and Sustainability Report

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Inari Medical, Inc. (NARI) releases its 2023 Ethos and Sustainability Report, showcasing its commitment to ESG initiatives. The report emphasizes the company's dedication to treating patients with venous and other diseases while prioritizing environmental and social responsibilities.
Positive
  • None.
Negative
  • None.

IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2023 Ethos and Sustainability Report. The report highlights Inari’s commitment to its ethos and important corresponding environmental, social and governance (ESG) initiatives. The report can be found on Inari’s website here.

“We are proud to issue our third annual Ethos and Sustainability Report and highlight the ESG-focused initiatives we implemented during the past year,” said Drew Hykes, CEO of Inari Medical.2023 was a great year for Inari, our patients, and our employees, as we focused on activities that embodied the Inari ethos. Our 2023 Ethos and Sustainability Report summarizes these activities and reflects the responsibility that we feel towards all stakeholders.”

Ethos and Sustainability Report

About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous disease, including venous thromboembolism, chronic venous disease and beyond. We are just getting started. Learn more at www.inarimedical.com and connect with us on LinkedIn, X (Twitter), and Instagram.

Investor Contact:
John Hsu, CFA
VP, Investor Relations
949-658-3889
IR@inarimedical.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2f0e90f3-8bd0-446f-a444-80c22e7d2d8b


FAQ

What did Inari Medical announce in its recent press release?

Inari Medical announced the publication of its 2023 Ethos and Sustainability Report.

What is the mission of Inari Medical?

Inari Medical's mission is to treat and transform the lives of patients suffering from venous and other diseases.

Who is the CEO of Inari Medical?

Drew Hykes is the CEO of Inari Medical.

Where can the 2023 Ethos and Sustainability Report be found?

The report can be found on Inari Medical's website.

What does the report highlight?

The report highlights Inari's commitment to its ethos and important corresponding ESG initiatives.

Inari Medical, Inc.

NASDAQ:NARI

NARI Rankings

NARI Latest News

NARI Stock Data

2.41B
52.39M
9.55%
94.14%
6.89%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
IRVINE

About NARI

inari medical is a medical device company pioneering devices for the interventional treatment of vascular thrombi and emboli.